Wiener klinische Wochenschrift Education

, Volume 2, Issue 2, pp 59–71 | Cite as

Tubuläre Nierenerkrankungen

  • Karl LhottaEmail author


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Yu X, White KE (2005) FGF23 and disorders of phosphate homeostasis. Cytokine Growth Factor Rev 16: 221–232PubMedCrossRefGoogle Scholar
  2. Quigley R (2006) Proximal renal tubular acidosis. J Nephrol 19 [Suppl 9]: S41–S45PubMedGoogle Scholar
  3. Scheinman SJ, Guay-Woodford LM, Thakker RV, Warnock DG (1999) Genetic disorders of renal electrolyte transport. N Engl J Med 340: 1177–1187PubMedCrossRefGoogle Scholar
  4. Yang CL, Angell J, Mitchell R, Ellison DH (2003) WNK kinases regulate thiazide-sensitive Na-Cl cotransport. J Clin Invest 111: 1039–1045PubMedCrossRefGoogle Scholar
  5. Mattsson C, Young WF Jr (2006) Primary aldosteronism: diagnostic and treatment strategies. Nat Clin Pract Nephrol 2: 198–208; quiz, 191 p following 230PubMedCrossRefGoogle Scholar
  6. Garovic VD, Hilliard AA, Turner ST (2006) Monogenic forms of low-renin hypertension. Nat Clin Pract Nephrol 2: 624–630PubMedCrossRefGoogle Scholar
  7. Ferrari P, Lovati E, Frey FJ (2000) The role of the 11beta-hydroxysteroid dehydrogenase type 2 in human hypertension. J Hypertens 18: 241–248PubMedCrossRefGoogle Scholar
  8. Hebert LA (2006) Optimizing ACE-inhibitor therapy for chronic kidney disease. N Engl J Med 354: 189–191PubMedCrossRefGoogle Scholar
  9. Juurlink DN, Mamdani MM, Lee DS, Kopp A, Austin PC, Laupacis A, Redelmeier DA (2004) Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. N Engl J Med 351: 543–551PubMedCrossRefGoogle Scholar
  10. Schrier RW (2006) Body water homeostasis: clinical disorders of urinary dilution and concentration. J Am Soc Nephrol 17: 1820–1832PubMedCrossRefGoogle Scholar
  11. Clarkson MR, Giblin L, O'Connell FP, O'Kelly P, Walshe JJ, Conlon P, O'Meara Y, Dormon A, Campbell E, Donohoe J (2004) Acute interstitial nephritis: clinical features and response to corticosteroid therapy. Nephrol Dial Transplant 19: 2778–2783PubMedCrossRefGoogle Scholar
  12. Choudhury D, Ahmed Z (2006) Drug-associated renal dysfunction and injury. Nat Clin Pract Nephrol 2: 80–91PubMedCrossRefGoogle Scholar
  13. Muranyi W, Bahr U, Zeier M, van der Woude FJ (2005) Hantavirus infection. J Am Soc Nephrol 16: 3669–3679PubMedCrossRefGoogle Scholar
  14. Mihatsch MJ, Khanlari B, Brunner FP (2006) Obituary to analgesic nephropathy – an autopsy study. Nephrol Dial Transplant 21: 3139–3145PubMedCrossRefGoogle Scholar
  15. Feinstein AR, Heinemann LA, Curhan GC, Delzell E, Deschepper PJ, Fox JM, Graf H, Luft FC, Michielsen P, Mihatsch MJ, Suissa S, Van Der Woude F, Willich S (2000) Relationship between nonphenacetin combined analgesics and nephropathy: a review. Ad Hoc Committee of the International Study Group on Analgesics and Nephropathy. Kidney Int 58: 2259–2264PubMedCrossRefGoogle Scholar
  16. Bogdanova N, Markoff A, Horst J (2002) Autosomal dominant polycystic kidney disease – clinical and genetic aspects. Kidney Blood Press Res 25: 265–283PubMedCrossRefGoogle Scholar
  17. Grantham JJ, Torres VE, Chapman AB, Guay-Woodford LM, Bae KT, King BF Jr, Wetzel LH, Baumgarten DA, Kenney PJ, Harris PC, Klahr S, Bennett WM, Hirschman GN, Meyers CM, Zhang X, Zhu F, Miller JP (2006) Volume progression in polycystic kidney disease. N Engl J Med 354: 2122–2130PubMedCrossRefGoogle Scholar
  18. Zhang Q, Taulman PD, Yoder BK (2004) Cystic kidney diseases: all roads lead to the cilium. Physiology (Bethesda) 19: 225–230Google Scholar
  19. Walz G (2006) Therapeutic approaches in autosomal dominant polycystic kidney disease (ADPKD): is there light at the end of the tunnel? Nephrol Dial Transplant 21: 1752–1757PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  1. 1.Klinische Abteilung für NephrologieUniversitätsklinik für Innere Medizin, Medizinische Universität InnsbruckAustria

Personalised recommendations